SCHEMBL24997232

SCHEMBL24997232

O=C1CCC(=O)N1c1ccc(OC(F)(F)F)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.59
LMNA P02545 2/20 0.54
GLA P06280 1/20 0.53
KMT2A Q03164 8/20 0.51
MEN1 O00255 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP2D6 P10635 1/20 0.51
MAPT P10636 1/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.50
SMN1; SMN2 Q16637 3/20 0.48
ATM Q13315 1/20 0.47
ALDH1A1 P00352 1/20 0.47
CA12 O43570 2/20 0.46
CA1 P00915 2/20 0.46
CA9 Q16790 2/20 0.46
GAA P10253 1/20 0.45
CA2 P00918 1/20 0.44
HPGD P15428 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28745022 0.82 MEN1 (0.49) POLBKMT2AMEN1CYP1A2CYP2D6
SCHEMBL6173519 0.80 AR (0.52) POLBKMT2AMEN1CYP1A2CYP2D6
SCHEMBL11536738 0.80 POLB (0.46) POLBKMT2AMEN1CYP1A2CYP2D6
SCHEMBL3006629 0.79 MGLL (0.58) POLBLMNAKMT2AMEN1CYP1A2
SCHEMBL32668241 0.78 POLB (0.70) POLBLMNAGLAKMT2AMAPT
SCHEMBL21383412 0.78 L3MBTL1 (0.54) POLBKMT2AMEN1CYP1A2CYP2D6
SCHEMBL11478927 0.77 CA12 (0.67) POLBLMNAGLAKMT2AMEN1
SCHEMBL5540336 0.75 KCNA5 (0.49) POLBKMT2AMEN1CYP1A2CYP2D6
SCHEMBL29168850 0.75 KMT2A (0.57) POLBLMNAKMT2AMEN1MAPT
SCHEMBL30758589 0.75 KMT2A (0.57) POLBLMNAKMT2AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230042881-A1 MODULATORS OF INTEGRATED STRESS RESPONSE PATHWAY Praxis Biotech LLC 2023-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230042881-A1 MODULATORS OF INTEGRATED STRESS RESPONSE PATHWAY ATF4, ATF1, DDIT3 POLB 2499/4885LMNA 4342/4885GLA 4606/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.